Eli Lilly's diabetes drug Mounjaro will be added to China's state health insurance from January 1, making it more accessible to the country...

Mounjaro has made a splash in Indian healthcare, emerging as the go-to solution for both diabetes management and weight loss. This remarkab...

The rising popularity of weight-loss drugs like Mounjaro and Wegovy is poised to create new opportunities for various sectors beyond pharma...

The drug clocked Rs 47-crore sales in July, double its June figure, according to data from prescriptions tracker PharmaTrac. If this month-...

Lilly stock latest news: Eli Lilly's Q2 earnings soared, fueled by Mounjaro and Zepbound's impressive sales, leading to raised full-year gu...

India is emerging as a key player in the global weight management industry, driven by a rising obesity crisis and the impending patent expi...

India's obesity drug market is set for intense competition with Novo Nordisk launching Wegovy to challenge Eli Lilly's Mounjaro, which gain...

Novo Nordisk, a Danish pharmaceutical company renowned for its diabetes medicines, is now positioning itself as the world's leading weight-...

The Danish pharmaceutical company Novo Nordisk has introduced its weight-loss drug Wegovy to the United Kingdom. This strategic expansion i...

Novo Nordisk's weight-loss drug, Wegovy, which has so far only been available as an injection, may soon come in pill form. Clinical trials ...

On TikTok, some videos featuring the hashtag Ozempic have been viewed more than a million times. Sponsored ads on Google promise weight los...